Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.57 |
| ▸ | HPGD | P15428 | 7/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.57 |
| ▸ | GAA | P10253 | 6/20 | 0.53 |
| ▸ | ACHE | P22303 | 5/20 | 0.53 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.53 |
| ▸ | CA12 | O43570 | 4/20 | 0.53 |
| ▸ | CA9 | Q16790 | 4/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | GLA | P06280 | 2/20 | 0.53 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.53 |
| ▸ | CASP1 | P29466 | 2/20 | 0.53 |
| ▸ | CASP7 | P55210 | 2/20 | 0.53 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | BCHE | P06276 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ayapin SCHEMBL6694210 | 1.00 | KDM4E (0.57) | KDM4EALDH1A1HPGDHSD17B10GAA | |
| SCHEMBL6843275 | 0.89 | KDM4E (0.57) | KDM4EALDH1A1HPGDHSD17B10GAA | |
| SCHEMBL28994323 | 0.82 | ALDH1A1 (0.59) | KDM4EALDH1A1HPGDHSD17B10GAA | |
| SCHEMBL12075314 | 0.77 | KDM4E (0.65) | KDM4EALDH1A1HPGDHSD17B10GAA | |
| SCHEMBL3277376 | 0.75 | GAA (0.49) | KDM4EALDH1A1HPGDHSD17B10GAA | |
| SCHEMBL6664851 | 0.75 | ALDH1A1 (0.63) | KDM4EALDH1A1HPGDHSD17B10GAA | |
| SCHEMBL6664850 | 0.75 | ALDH1A1 (0.63) | KDM4EALDH1A1HPGDHSD17B10GAA | |
| Dihydro-Obliquin SCHEMBL12062091 | 0.74 | ALDH1A1 (1.00) | KDM4EALDH1A1HPGDHSD17B10GAA | |
| SCHEMBL4740620 | 0.74 | GAA (0.48) | KDM4EALDH1A1HPGDHSD17B10GAA | |
| SCHEMBL15842745 | 0.74 | CA9 (0.59) | KDM4EALDH1A1HPGDHSD17B10GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250074925-A1 | RARE EARTH COMPLEX | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2025-03-06 | — | — | US | disclosed |
| EP-4479540-A1 | COUMARIN SYNTHESIS AND USES THEREOF | BASF SE (DE) | 2024-12-25 | — | — | EP | disclosed |
| EP-4405378-A1 | COUMARIN TRANSPORTERS AND USES THEREOF | BASF Plant Science Company GmbH (DE) | 2024-07-31 | — | — | EP | disclosed |
| EP-4365180-A1 | RARE EARTH COMPLEX | Tosoh Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| CN-117616032-A | Rare earth complex | 东曹株式会社 | 2024-02-27 | — | — | CN | disclosed |
| WO-2023156270-A1 | COUMARIN SYNTHESIS AND USES THEREOF | BASF SE (DE) | 2023-08-24 | — | — | WO | disclosed |
| WO-2023041649-A1 | COUMARIN TRANSPORTERS AND USES THEREOF | BASF PLANT SCIENCE COMPANY GMBH (DE) | 2023-03-23 | — | — | WO | disclosed |
| WO-2023282236-A1 | RARE EARTH COMPLEX | 東ソー株式会社 | 2023-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250074925-A1 | RARE EARTH COMPLEX | L1CAM, CHRM1, NPM1 | KDM4E 4590/4885ALDH1A1 2286/4885HPGD 2990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.